Physicians collaborating with Retrotope previously received approval from the FDA to test RT001 in Expanded Access trials of two patients having Infantile Neuroaxonal Dystrophy. Source: BioSpace
For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research. Source: BioSpace
Aisling Capital today announced the closing of its newest fund, with $280M in committed capital. Source: BioSpace
Dicerna and Boehringer Ingelheim today announced a research collaboration and license agreement to discover and develop novel RNAi therapeutics for the treatment of chronic liver diseases. Source: BioSpace
Despite Brandicourt's positive spin, investors were displeased as the company's financial report fell shy of analysts' expectations. Source: BioSpace
As part of strategic restructuring, Proteostatis is laying off 46 percent of its R&D workforce, or 13 positions. Source: BioSpace
The company submitted 15 abstracts to be presented at the upcoming ASH Conference. Source: BioSpace
ALZ’s researchers continue to see hope in Biogen's aducanumab. Source: BioSpace
The European Medicines Agency revised its 2009 guideline on developing treatments for axial spondyloarthritis, accounting for changes in clinical practice. Source: Drug Industry Daily
A multistate price-fixing lawsuit against generic drugmakers should be dramatically expanded to target more drugs, more companies and, for the first time, individual company executives, the attorneys general who filed…